With Trials In Motion, Cash To 2027, Can Kyverna’s Next Data Drop Turn The Stock Around?

All NewsMay 27, 2025

HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent